Patents by Inventor Zhiyuan Yang

Zhiyuan Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250123418
    Abstract: The present invention relates to the field of coal mine concealed fire zone detection, in particular to a coal spontaneous combustion downhole detection system and method based on a self-potential method. The coal spontaneous combustion downhole detection system comprises a self-potential detection apparatus and a self-potential processing apparatus; the self-potential detection apparatus comprises measuring electrodes, a reference electrode and metal anchor rods; the measuring electrodes are arranged on a top plate of a goaf roadway, are fixed to the metal anchor rods, and are in wireless connection with the reference electrode through the metal anchor rods; the self-potential processing apparatus comprises a data processing sensor for processing potential data and an imaging sensor for converting data into images; and the measuring electrodes and the reference electrode are in wireless connection with the data processing sensor.
    Type: Application
    Filed: September 5, 2024
    Publication date: April 17, 2025
    Inventors: Xiangming HU, Hao DONG, Baiqian WU, Shijian YU, Shengli WANG, Yong ZHOU, Wenqi SHAO, Wei WANG, Mingyue WU, Fusheng WANG, Lijun LI, Haozhen XUAN, Zhiyuan YANG
  • Publication number: 20250109390
    Abstract: The present application relates to compositions for preventing or treating infections. In some embodiments, the present application provides chimeric proteins comprising a target-binding moiety comprising an extracellular binding domain (EBD) of an angiotensin-converting enzyme 2 (ACE2) protein or a fragment thereof that specifically binds to an S protein, and a positively charged mucoadhesive peptide fragment. Compositions comprising the chimeric proteins described herein are useful for preventing or treating a viral infection in an individual, such as a coronavirus infection.
    Type: Application
    Filed: October 11, 2024
    Publication date: April 3, 2025
    Inventors: Cheng LIU, Hongbing ZHANG, Ziyou CUI, Zhiyuan YANG, Jinyun CHEN, Jingbao LIU, Guangyan XIONG, Warner GREENE
  • Publication number: 20250034235
    Abstract: The present application provides chimeric proteins comprising an antibody moiety that specifically binds to a component of an influenza virus or a variant thereof, and a positively charged mucoadhesive peptide fragment. Compositions comprising the chimeric proteins described herein are useful for preventing or treating an infection caused by an influenza virus or a variant thereof in an individual.
    Type: Application
    Filed: October 11, 2024
    Publication date: January 30, 2025
    Inventors: Cheng LIU, Ziyou CUI, Hongbing ZHANG, Zhiyuan YANG, Guangyan XIONG, Lu JIN, Jinyun CHEN, Motao LIU, Warner GREENE
  • Publication number: 20250011463
    Abstract: The present application provides constructs comprising an antibody moiety that specifically binds to PSMA (e.g., PSMA expressed on the surface of a cell). Also provided are methods of making and using these constructs.
    Type: Application
    Filed: April 19, 2024
    Publication date: January 9, 2025
    Inventors: Hong LIU, Hongruo YUN, Xiaomei GE, Zhiyuan YANG, Lianxing LIU, Pengbo ZHANG, Yixiang XU, Shan LI, Lucas HORAN
  • Patent number: 11993661
    Abstract: The present application provides constructs comprising an antibody moiety that specifically binds to PSMA (e.g., PSMA expressed on the surface of a cell). Also provided are methods of making and using these constructs.
    Type: Grant
    Filed: June 17, 2019
    Date of Patent: May 28, 2024
    Assignee: EUREKA THERAPEUTICS, INC.
    Inventors: Hong Liu, Hongruo Yun, Xiaomei Ge, Zhiyuan Yang, Lianxing Liu, Pengbo Zhang, Yixiang Xu, Shan Li, Lucas Horan
  • Patent number: 11981742
    Abstract: Described herein are human antibody agents and multi-specific binding agents that specifically bind human CD 19, in particular, native human CD 19. Also provided herein are methods of using the same or compositions thereof for the detection, prevention and/or therapeutic treatment of diseases characterized by CD 19 expression, in particular, B cell lymphomas and leukemias.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: May 14, 2024
    Assignee: Eureka Therapeutics, Inc.
    Inventors: Hong Liu, Jingwei Lu, Zhiyuan Yang, Li Long, Neal Cheng
  • Patent number: 11976105
    Abstract: The present application provides antibody-TCR chimeric constructs comprising an antibody moiety that specifically binds to a target antigen fused to a TCRM capable of recruiting at least one TCR-associated signaling module. Also provided are methods of making and using these constructs.
    Type: Grant
    Filed: February 22, 2021
    Date of Patent: May 7, 2024
    Assignee: EUREKA THERAPEUTICS, INC.
    Inventors: Jingwei Lu, Zhiyuan Yang, Cheng Liu, Hong Liu, Yiyang Xu, Su Yan, Vivien Wai-Fan Chan, Lucas Horan
  • Publication number: 20230374140
    Abstract: The present technology relates generally to compositions that specifically recognize and bind to a NDC80 peptide complexed with a major histocompatibility antigen (e.g., HLA-A*02). The compositions of the present technology are useful in methods for treating NDC80-associated diseases (e.g., cancers) in a subject in need thereof.
    Type: Application
    Filed: October 8, 2021
    Publication date: November 23, 2023
    Inventors: Martin KLATT, Tao DAO, David A. SCHEINBERG, Zhiyuan YANG, Jianying LIU
  • Publication number: 20230330815
    Abstract: A Block-Type structured diamond grinding wheel with adaptive supply of instantaneous Cooling, includes a grinding wheel substrate and several grinding wheel units, each including an execution mechanism, a push mechanism, and an instantaneous Cooling mechanism. Various structured patterns are provided on an upper surface of the grinding unit in the execution mechanism, and a heat sink is disposed at a lower surface. During operation, a tangential grinding force generated by the grinding unit and a workpiece presses a sprayer to spray nano fluid into an operating region, to implement instantaneous Cooling of grinding wheel. When wear occurs in a grinding unit of a grinding wheel, a corresponding grinding unit may be replaced to extend the service life of the grinding wheel, and production costs are reduced. A special surface structure of the grinding unit further enhances a cooling effect, thereby improving a surface quality of a workpiece.
    Type: Application
    Filed: June 21, 2023
    Publication date: October 19, 2023
    Inventors: Jiaming LIU, XIaohong ZHANG, Liwei NING, Jia DUAN, Xiong TANG, Wei LI, Zhiyuan YANG, Wanyi TIAN, Shiguo TENG
  • Publication number: 20230293687
    Abstract: Described herein are immune cells comprising: a T-cell receptor (TCR) and a chimeric stimulating receptor (CSR) that comprises (i) a ligand-binding module that is capable of binding or interacting with a target ligand; (ii) a transmembrane domain; and (iii) a CD30 costimulatory domain, in which the CSR in the immune cells lacks a functional primary signaling domain. Also provided herein are methods of using the same or components thereof (e.g., the CSR) for therapeutic treatment of cancers (e.g., solid tumor cancers).
    Type: Application
    Filed: July 29, 2021
    Publication date: September 21, 2023
    Inventors: Cheng Liu, Hongbing Zhang, Zhiyuan Yang, Pengbo Zhang, Yixiang Xu, Guangyuan Xiong, Ziyou Cui
  • Publication number: 20230141962
    Abstract: The present application relates to compositions for preventing or treating viral and other microbial infections. In some embodiments, the present application provides chimeric proteins comprising a target-binding moiety that specifically binds to a pathogen that infects through a mucosa, and a positively charged mucoadhesive peptide fragment. Also provided are antibodies and constructs thereof that specifically binds to an S1 subunit of a spike protein of SARS-CoV-2. Compositions comprising the chimeric proteins, antibodies, or constructs described herein are useful for preventing or treating a microbial infection in an individual, such as a coronavirus infection.
    Type: Application
    Filed: August 4, 2022
    Publication date: May 11, 2023
    Inventors: Cheng LIU, Hongbing Zhang, Zhiyuan Yang, Jingyi Xiang, Ziyou Cui, Jianying Liu
  • Patent number: 11613573
    Abstract: The present application provides chimeric antibody-TCR constructs comprising an antigen-binding module that specifically binds to a target antigen and a T cell receptor module capable of recruiting at least one TCR-associated signaling molecule. Also provided are methods of making and using these constructs.
    Type: Grant
    Filed: April 24, 2018
    Date of Patent: March 28, 2023
    Assignee: EUREKA THERAPEUTICS, INC.
    Inventors: Lucas Horan, Yiyang Xu, Zhiyuan Yang, Hong Liu, Javier Morales, Lianxing Liu
  • Publication number: 20220348629
    Abstract: The present application provides antibody-TCR chimeric constructs comprising an antibody moiety that specifically binds to a target antigen fused to a TCRM capable of recruiting at least one TCR-associated signaling module. Also provided are methods of making and using these constructs.
    Type: Application
    Filed: April 8, 2022
    Publication date: November 3, 2022
    Inventors: Jingwei LU, Zhiyuan YANG, Cheng LIU, Hong LIU, Yiyang XU, Su YAN, Vivien Wai-Fan CHAN, Lucas HORAN
  • Patent number: 11440952
    Abstract: The present application relates to compositions for preventing or treating viral and other microbial infections. In some embodiments, the present application provides chimeric proteins comprising a target-binding moiety that specifically binds to a pathogen that infects through a mucosa, and a positively charged mucoadhesive peptide fragment. Also provided are antibodies and constructs thereof that specifically binds to an S1 subunit of a spike protein of SARS-CoV-2. Compositions comprising the chimeric proteins, antibodies, or constructs described herein are useful for preventing or treating a microbial infection in an individual, such as a coronavirus infection.
    Type: Grant
    Filed: October 14, 2021
    Date of Patent: September 13, 2022
    Assignee: InvisiShield Technologies Ltd.
    Inventors: Cheng Liu, Hongbing Zhang, Zhiyuan Yang, Jingyi Xiang, Ziyou Cui, Jianying Liu
  • Publication number: 20220267420
    Abstract: Provided herein are compositions, kits, and methods for manufacturing cells for adoptive cell therapy comprising (a) an engineered receptor, vector encoding an engineered receptor, or engineered immune cell expressing such engineered receptor or comprising such vector; and (b) a Fox P3 targeting agent.
    Type: Application
    Filed: February 14, 2019
    Publication date: August 25, 2022
    Applicants: Memorial Sloan Kettering Cancer Center, Eureka Therapeutics, Inc.
    Inventors: David A. SCHEINBERG, Cheng LIU, Zhiyuan YANG, Lianxing LIU, Shaohua Xu, Pei WANG, Yiyang XU
  • Patent number: 11421013
    Abstract: The present application provides antibody-TCR chimeric constructs comprising an antibody moiety that specifically binds to a target antigen fused to a TCRM capable of recruiting at least one TCR-associated signaling module. Also provided are methods of making and using these constructs.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: August 23, 2022
    Assignee: EUREKA THERAPEUTICS, INC.
    Inventors: Jingwei Lu, Zhiyuan Yang, Cheng Liu, Hong Liu, Yiyang Xu, Su Yan, Vivien Wai-Fan Chan, Lucas Horan
  • Publication number: 20220185910
    Abstract: The present application provides constructs comprising an antibody moiety that specifically binds to PSMA (e.g., PSMA expressed on the surface of a cell). Also provided are methods of making and using these constructs.
    Type: Application
    Filed: June 17, 2019
    Publication date: June 16, 2022
    Inventors: Hong LIU, Hongruo YUN, Xiaomei GE, Zhiyuan YANG, Lianxing LIU, Pengbo ZHANG, Yixiang XU, Shan LI, Lucas HORAN
  • Publication number: 20220119501
    Abstract: The present application relates to compositions for preventing or treating viral and other microbial infections. In some embodiments, the present application provides chimeric proteins comprising a target-binding moiety that specifically binds to a pathogen that infects through a mucosa, and a positively charged mucoadhesive peptide fragment. Also provided are antibodies and constructs thereof that specifically binds to an S1 subunit of a spike protein of SARS-CoV-2. Compositions comprising the chimeric proteins, antibodies, or constructs described herein are useful for preventing or treating a microbial infection in an individual, such as a coronavirus infection.
    Type: Application
    Filed: October 14, 2021
    Publication date: April 21, 2022
    Inventors: Cheng LIU, Hongbing ZHANG, Zhiyuan YANG, Jingyi XIANG, Ziyou CUI, Jianying LIU
  • Publication number: 20210253665
    Abstract: The present application provides antibody-TCR chimeric constructs comprising an antibody moiety that specifically binds to a target antigen fused to a TCRM capable of recruiting at least one TCR-associated signaling module. Also provided are methods of making and using these constructs.
    Type: Application
    Filed: February 22, 2021
    Publication date: August 19, 2021
    Inventors: Jingwei LU, Zhiyuan YANG, Cheng LIU, Hong LIU, Yiyang XU, Su YAN, Vivien Wai-Fan CHAN, Lucas HORAN
  • Publication number: 20210101954
    Abstract: The present application provides chimeric antibody-TCR constructs comprising an antigen-binding module that specifically binds to a target antigen and a T cell receptor module capable of recruiting at least one TCR-associated signaling molecule. Also provided are methods of making and using these constructs.
    Type: Application
    Filed: April 24, 2018
    Publication date: April 8, 2021
    Inventors: Lucas HORAN, Yiyang XU, Zhiyuan YANG, Hong LIU, Javier MORALES, Lianxing LIU